BFM
VYGR icon

Boothbay Fund Management’s Voyager Therapeutics VYGR Stock Holding History

Boothbay Fund Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,144
Closed -$56.7K – 2412
2025
Q3 		$56.7K Hold
12,144
– – ﹤0.01% 1773
2025
Q2 		$37.8K Hold
12,144
– – ﹤0.01% 1369
2025
Q1 		$41K Sell
12,144
-782
-6% -$3.65K ﹤0.01% 1297
2024
Q4 		$73.3K Buy
12,926
+691
+6% +$4.46K ﹤0.01% 1322
2024
Q3 		$71.6K Hold
12,235
– – ﹤0.01% 1482
2024
Q2 		$96.8K Sell
12,235
-27,382
-69% -$230K ﹤0.01% 1353
2024
Q1 		$369K Sell
39,617
-27,380
-41% -$231K 0.01% 1129
2023
Q4 		$565K Hold
66,997
– – 0.01% 944
2023
Q3 		$519K Buy
66,997
+5,857
+10% +$53.5K 0.01% 1019
2023
Q2 		$700K Buy
61,140
+49,324
+417% +$510K 0.02% 971
2023
Q1 		$91.1K Sell
11,816
-3,387
-22% -$26.9K ﹤0.01% 1961
2022
Q4 		$92.7K Buy
+15,203
New +$86.4K ﹤0.01% 1806

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boothbay Fund Management's VYGR Position: Q4 2025 in Review

Boothbay Fund Management sold out of Voyager Therapeutics (VYGR) in Q4 2025, closing a stake of 12,144 shares — an estimated $56.7K sold.

Boothbay Fund Management first reported a position in VYGR in Q4 2022 and held it in 12 quarters. The position peaked at $700K in Q2 2023. 125 funds tracked by Wall St. Rank hold VYGR as of Q4 2025.

  • Boothbay Fund Management reported no remaining Voyager Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 12,144 Voyager Therapeutics shares in Q4 2025, an estimated $56.7K.
  • Boothbay Fund Management first reported a position in Voyager Therapeutics in Q4 2022 and held it in 12 quarters.
  • Boothbay Fund Management's Voyager Therapeutics position peaked at $700K in Q2 2023.
  • 125 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.